| Company Name | Disruptyx Therapeutics Limited |
|---|---|
| Director | Douglas Fraser Gray |
| Company Status | Active |
| Company Number | SC731650 |
| Category | Private Limited Company |
| Incorporation Date | 6 May 2022(1 year, 11 months ago) |
| Previous Name | Disruptyve Therapeutics Limited |
Business Activity
| Section M | Professional, scientific and technical activities |
|---|---|
| SIC 72110 | Research and experimental development on biotechnology |
Director
| Director Name | Dr Douglas Fraser Gray |
|---|---|
| Date of Birth | October 1965 (Born 58 years ago) |
| Nationality | British |
| Status | Current |
| Appointed | 06 May 2022(same day as company formation) |
| Role | Company Director |
| Country of Residence | England |
| Correspondence Address | 11 The Square University Avenue Glasgow G12 8QQ Scotland |
Location
| Registered Address | 11 The Square University Avenue Glasgow G12 8QQ Scotland |
|---|---|
| Constituency | Glasgow North |
| Ward | Hillhead |
| Address Matches | 3 other UK companies use this postal address |
Accounts
| Latest Accounts | 31 May 2023 (11 months ago) |
|---|---|
| Next Accounts Due | 28 February 2025 (10 months, 1 week from now) |
| Accounts Category | Dormant |
| Accounts Year End | 31 May |
Returns
| Latest Return | 5 May 2023 (11 months, 3 weeks ago) |
|---|---|
| Next Return Due | 19 May 2024 (3 weeks, 1 day from now) |
Filing History
| 27 October 2023 | Accounts for a dormant company made up to 31 May 2023 (2 pages) |
|---|---|
| 21 June 2023 | Confirmation statement made on 5 May 2023 with updates (4 pages) |
| 20 September 2022 | Notification of Connor William Blair as a person with significant control on 12 September 2022 (2 pages) |
| 20 September 2022 | Notification of George Scott Baillie as a person with significant control on 12 September 2022 (2 pages) |
| 16 September 2022 | Change of details for Dr Douglas Fraser Gray as a person with significant control on 12 September 2022 (2 pages) |
| 16 September 2022 | Statement of capital following an allotment of shares on 12 September 2022
|
| 19 May 2022 | Company name changed disruptyve therapeutics LIMITED\certificate issued on 19/05/22
|
| 6 May 2022 | Incorporation Statement of capital on 2022-05-06
|